Health

Market access

Strategy and execution across the product lifecycle

LCP Health Market Access services help life sciences companies navigate uncertainty and maximise asset value across the product lifecycle, from early development through launch, growth, and maturity.

We enable successful market access by combining rigorous analytics, deep market insight, and execution expertise across pricing and reimbursement. We help clients build evidence-based strategies, define clear pricing and access positions, and engage key decision-makers effectively to drive sustainable success across diverse healthcare systems.

Our tailored approach delivers integrated market access insights throughout the product lifecycle, translating value strategies into locally relevant coverage and contracting solutions that resonate with payers, HTA bodies, providers, advisors and patients.

Our featured insights

We link value and access strategies to local health system needs and priorities

At LCP Health, we help clients secure reimbursement and access by translating product value into practical, real-world solutions that enable the right patients to receive the right treatments at the right time.

We partner with clients to identify and overcome clinical, economic, and system-level barriers to access, integrating evidence generation, reimbursement strategy, and patient outcomes. Our data-driven approach ensures access pathways are feasible, scalable, and aligned with local healthcare requirements across markets and care settings.

By connecting value strategy with execution across reimbursement, channels, and patient ecosystems, we support sustainable, consistent access, reducing patient burden while meeting the needs of payers, providers, and health systems worldwide.

At LCP Health, we support our clients across the following areas:

Evidence and access foundations

We help establish the clinical, economic, and pathway foundations required to support to support HTA, reimbursement and payer decision-making.

Payer evidence gap analysis and payer rationalised clinical trial design
Landscape analyses, including clinical, pricing and reimbursement, competitive and HTA Landscape
Pathway mapping (clinical and reimbursement)
Patient and provider segmentation

Market access strategy and insights

We support strategic decision-making across portfolios and individual assets by providing clear, evidence-based direction on access risk and opportunity.

Market access strategy / roadmap development
Portfolio planning including indication sequencing
Business development / licensing evaluation (opportunity assessment / asset due diligence)
Analogue analysis
Payer segmentation
Payer research / advisory boards

Pricing, reimbursement and contracting

We design pricing and contracting strategies to support HTA, reimbursement and payer decision-making

Strategic and tactical pricing analysis contracting strategy and tactics

Payer budget / impact modelling

Gross-to-Net (GTN) and revenue forecast modelling

Payer value and communications

Payer value story / messaging
Global value dossier strategy and development
Payer value decks and access toolkits
Internal training and preparedness (inc., objection handling and payer simulation workshops)
Payer focused publications
HTA strategy and submission support
Pre-approval Information Exchange (PIE) materials, including PIE deck and AMCP dossier development

US-focused market access services:

Trade and channel

We support trade and distribution strategy from design through implementation to ensure access readiness and execution excellence.

Trade and channel strategy, design and readiness through implementation execution
Established channel operations review and optimisation
Trade and channel partner contracting and onboarding (e.g., development, negotiation, redlines and execution)
Financial impact modelling

Patient services

We design and optimise patient support solutions that remove access barriers while managing operational and financial risk.

Patient services strategy and design
Program implementation support
Patient Support Program (PSP) and Field Reimbursement Manager (FRM) satisfaction
Program operational review
Financial exposure modelling